Corton Capital’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-12,159
Closed -$73.2K 165
2024
Q4
$73.2K Buy
+12,159
New +$73.2K 0.04% 359